ORLANDO—Dutasteride, a drug widely prescribed for treating benign prostatic enlargement, lowers the risk of prostate cancer PCa progression in men undergoing active surveillance for the disease, researchers concluded.
via Dutasteride Slows Prostate Cancer Progression – Renal and Urology News.
Dutasteride has been used for BPH and is thought to help reduce the risk of developing prostate cancer. This study also supports its use for men on active surveillance. The medicine is mostly used for the treatment of benign enlargement of the prostate and can have sexual side effects in a small percentage of men.